SABMiller’s Mackay Steps Back After ‘Sudden Worsening’ of Health

Nov. 15 (Bloomberg) -- SABMiller Plc, the world’s second-biggest brewer, said Chairman Graham Mackay is taking a further leave of absence after a “recent sudden worsening” of his health following brain surgery earlier this year.

Deputy Chairman John Manser has been re-appointed as acting chairman, a role he held for five months during Mackay’s initial recovery, the London-based company said today in a statement.

Mackay only returned as chairman two months ago, having been off work following treatment for a brain tumor.

In April, he stepped down early as the brewer’s chief executive officer, a role in which he masterminded a slew of acquisitions, including the A$10.5 billion ($9.8 billion) takeover of Foster’s Group Ltd. in 2011. Alan Clark, a company veteran of more than two decades, replaced Mackay as CEO.

To contact the reporter on this story: Paul Jarvis in London at pjarvis@bloomberg.net

To contact the editor responsible for this story: Celeste Perri at cperri@bloomberg.net